Targeting CD33 for acute myeloid leukemia therapy
Sign Up to like & getrecommendations! Published in 2022 at "BMC Cancer"
DOI: 10.1186/s12885-021-09116-5
Abstract: Background The aim of this study was to analyze the level of CD33 expression in patients with newly diagnosed AML and determine its correlation with clinical characteristics. Methods Samples were collected for analysis from AML… read more here.
Keywords: targeting cd33; expression; analysis; level cd33 ... See more keywords
Extraordinarily elevated CD33 expression in CD56+CD3– cells in the bone marrow of a patient with relapsed acute myeloid leukemia: a case report
Sign Up to like & getrecommendations! Published in 2021 at "Translational Cancer Research"
DOI: 10.21037/tcr-21-733
Abstract: Based on genetic risk allogeneic stem cell transplantation (allo-SCT) is the only curative treatment for some forms of acute myeloid leukemia (AML). However, post-transplantation relapse remains a frequent cause of transplantation failure. Natural killer (NK)… read more here.
Keywords: expression; patient; cd3 cells; cd56 cd3 ... See more keywords
Detection of CD33 expression on monocyte surface is influenced by phagocytosis and temperature.
Sign Up to like & getrecommendations! Published in 2019 at "General physiology and biophysics"
DOI: 10.4149/gpb_2019021
Abstract: CD33 is a myeloid-associated marker and belongs to the sialic acid-binding immunoglobulin (Ig)-like lectin (Siglec) family. Such types of receptors are highly expressed in acute myeloid leukemia, which could be used in its treatment. CD33… read more here.
Keywords: cd33; surface; cd33 expression; detection cd33 ... See more keywords